Ubulwele bwa Alzheimer bulwele bwa kuli bongobongo ubulenga insandesande sha kuli bongobongo ukuleka ukubomba bwino no kufwa, ne ci cilenga umuntu ukuleka ukwibukisha ifintu, ukutontonkanya bwino, no kutontonkanya bwino.
E cilenga sana abantu ukulalwala ubu bulwele, kabili e bulenga abantu abengi ukulalwala ubu bulwele.
Ubu bulwele bulapwisha ubumi, kabili umuntu nga bamupima kuti aikala imyaka 4 ukufika ku 8, nangu ca kuti abantu bamo kuti baikala imyaka 20 no bulwele.
Impendwa ya bafwa ku bulwele bwa Alzheimer ilapusanapusana ukulingana no kusambilila ne mpendwa ya bantu abalesangwa muli uku kusambilila.
Ukulingana ne kabungwe ka Alzheimer's Association, ubulwele bwa Alzheimer e bulenga 6 pa filenga abantu ukufwa mu United States, kabili e bulenga 5 pa filenga abantu ukufwa abali ne myaka 65 no kucilapo.
Mu 2019, ubulwele bwa Alzheimer bwaishibikwe ukuti e bwalenga abantu 121,9444 ukufwa mu United States.
Zhu B, Chen X, Li W, Zhou D: Effect of Alzheimer Disease on Prognosis of Intensive Care Unit (ICU) Patients: A Propensity Score Matching Analysis. Med Sci Monit. 2022, 28 (): e935397.
Almeida MC, Gomes Cde M, Nascimento LF: Spatial distribution of deaths due to Alzheimer's disease in the state of São Paulo, Brazil. Sao Paulo Med J. 2014, 132 (4): 199-204.
Aevarsson O, Svanborg A, Skoog I: Seven-year survival rate after age 85 years: relation to Alzheimer disease and vascular dementia. Arch Neurol. 1998, 55 (9): 1226-32.
Breitner JC: Clinical genetics and genetic counseling in Alzheimer disease. Ann Intern Med. 1991, 115 (8): 601-6.
Iulita MF, Garzón Chavez D, Klitgaard Christensen M, Valle Tamayo N, Plana-Ripoll O, Rasmussen SA, Roqué Figuls M, Alcolea D, Videla L, Barroeta I, Benejam B, Altuna M, Padilla C, Pegueroles J, Fernandez S, Belbin O, Carmona-Iragui M, Blesa R, Lleó A, Bejanin A, Fortea J: Association of Alzheimer Disease With Life Expectancy in People With Down Syndrome. JAMA Netw Open. 2022, 5 (5): e2212910.
['Ukufumyamo: kwa cipatala']
['Iyi webusaiti yabelako ku kusambilisha fye abantu kabili te ya kubomfya pa kundapa.']
['Ifyebo fyaba pali iyi webusaiti tafifwile ukubomfiwa ku kwishiba ubulwele umuntu akwete nelyo ukuundapa ubulwele, kabili abafwaya ukupanda amano pa fya kundapwa bafwile ukuipusha badokota.']
['Moneni ukuti neural net iileasuka ifipusho, ilingi line tailondolola bwino bwino ifyebo, pamo nga impendwa ya bantu abalwala ubulwele bumo.']
['Lyonse muleipusha badokota nelyo ababomfi ba cipatala pa fyo mwingacita pa bumi bwenu. Mwilaleka ukumfwa ifyo badokota balanda pa mulandu wa fyebo mwabelenga pali iyi webusaiti. Nga mwamona ukuti namulwala ubulwele ubukalamba, mufwile ukwita bwangu ku cipatala. Iyi webusaiti nelyo ifyo mubomfya iyi webusaiti tafilenga mwaumfwana na badokota nelyo abalwele. BioMedLib na babomfi baiko, nelyo abaibikamo, tabapeelako uuli onse umulandu, nangu fye ni mu kulungatika nelyo mu kukanailanda, pa fyebo fyaba pali iyi webusaiti nelyo ifyo babomfya.']
['Ukufumyamo: insambu sha kulemba']
['Ifunde lya Digital Millennium Copyright Act ilya mu 1998, 17 U.S.C. § 512 (the DMCA) lyapeela inshila sha kupwishishamo ubwafya ku bene ba fipe abaishiba ukuti ifyebo fyaba pa Intaneti filatoba insambu shabo ukulingana ne funde lya U.S. pa fya mafunde ya kuicingilila. ']
['Nga mwamona ukuti ifyebo fimo nelyo ifintu fimbi ifyo babika pa webusaiti yesu nelyo pa milimo yesu fyalipula mu nsambu sha bene, imwe (nangu umwiminishi wenu) kuti mwatutumina kalata ya kutweba ukuti tufumye ifyo fyebo nelyo ifyo fintu, nelyo ukuti tuleke ukufibomfya. ']
['Ukutumina abantu amameseji pa Intaneti (moneni akabokoshi akaleti "Kutuminako Bamunyinefwe" pa kuti mwishibe ama adresi ya pa Intaneti) ].']
['Ifunde lya DMCA litila mu mashiwi ya musango wa kuti umuntu nacita ifyo mulefwaya, mufwile ukulembapo ifyebo pamo nga: (1) ifyo icitabo ico mulefwaya ukupeela abantu e co balefwaya ukupeela abantu; (2) ifyo icitabo ico mulefwaya ukupeela abantu e co balefwaya ukupeela abantu; (3) ifyo mwingatutumina ifyebo, pamo nga adresi yenu, inambala ya foni, e lyo na adresi ya e-mail; (4) ifyo mwingalanda ukuti mulesumina ukuti ifyo mulefwaya ukupeela abantu te fyo umwine wa ici citabo, nelyo umwiminishi wakwe, nelyo ifunde limbi lyalanda. ']
['(5) amashiwi yenu ayalembwa, aya kuti nga mwafilwa ukulemba, mukapeelwa umulandu wa bufi, ukuti ifyebo fyaba muli aya mashiwi fya cine kabili mwalikwata amaka ya kucingilila insambu sha bene isho mulefwaya ukufyenga; ']
['Kabili (6) ukusuminisha kwa mwine wa fipe nelyo ukwa muntu uwapeelwa insambu sha kucita ifintu pa mulandu wakwe. ']
['Mukwai tumeni kalata ya ku email pa kwipusha icili conse nelyo ukutupeela amano.']
How deadly is alzheimer?
Alzheimer's disease is a progressive neurological disorder that causes brain cells to degenerate and die, leading to a decline in memory, thinking, and reasoning skills.
It is the most common cause of dementia, accounting for 60-80% of all cases.
The disease is ultimately fatal, with the average life expectancy after diagnosis being 4-8 years, although some people can live up to 20 years with the disease.
The mortality rate for Alzheimer's disease varies depending on the study and the population being examined.
According to the Alzheimer's Association, Alzheimer's disease is the sixth leading cause of death in the United States, and it is the fifth leading cause of death for those aged 65 and older.
In 2019, Alzheimer's disease was reported as the underlying cause of death for 121,9444 people in the United States.
It is important to note that the mortality rate for Alzheimer's disease is not solely due to the disease itself, but also due to complications and other health issues that arise as a result of the disease.
As the disease progresses, individuals may experience difficulty with activities of daily living, such as eating, bathing, and dressing, which can lead to malnutrition, infections, and other health problems.
Additionally, individuals with Alzheimer's disease may be at an increased risk of falls, pneumonia, and other infections.
While there is currently no cure for Alzheimer's disease, there are treatments available that can help manage symptoms and improve quality of life.
Research is ongoing to develop new treatments and ultimately find a cure for this devastating disease.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Pa lwa']
['BioMedLib ibomfya amakompyuta ayabomba (amakompyuta ayaishiba ukulemba) pa kupanga ifipusho ne fyasuko.']
['Twatendekelepo ne mpapulo sha mu fipatala 35 milioni isha mu PubMed/Medline.']
